NANOG and acute myeloid leukemia: Silencing of Nanog as a transcription factor for LSCs has been demonstrated to suppress the proliferative ability and facilitate apoptotic and cell cycle arrest potential of AML-LSC which is modulated with the insulin-like growth factor receptor (IGF1R) pathway.207